| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |